我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

内皮素与充血性心力衰竭(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2003年第3期
页码:
262-264
栏目:
综述
出版日期:
2003-05-01

文章信息/Info

Title:
-
作者:
张小勇综述; 光雪峰审校
昆明医学院第二附属医院心内科,云南 昆明 650031
Author(s):
-
关键词:
内皮素; 受体; 心力衰竭
Keywords:
-
分类号:
R541.61,R362
DOI:
-
文献标识码:
A
摘要:
内皮素与充血性心力衰竭的发生发展及疾病的预后密切相关。抑制内皮素的作用可改善心衰患者的血流动力学,缓解患者的症状,可否改善患者的长期预后有待进一步证实。
Abstract:
-

参考文献/References

[1]Verhaar MC,Strachan FE,Newby DE,et al.Endothelin-A receptor antagonist-mediated vasodilation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade [J]. Circulation,1998,97(8):752-756.

[2]Ponicke K,Vogelsang M,Heiroth M,etal.Endothelin receptors in the failing and nonfailing heart [J].Circulation,1998,97:744-751.

[3] MacCarthy P Y,Grocott-Mason R,Prendergast BD,et al.Contrasting inotropic effects of endogeneous endothelin in the normal and failing human heart [J]. Circulation,2000,101:142-147

. [4] Kobayshi T,Miyauchi T,Sakai S,et al.Down regulation of ET (B) receptor, but not ET(A) receptor, in congetive lung secondary to heart failure. Are marked increase in circulating endothelin-1 partly attributable to decrease in lung ET(B) receptor-mediated clearance of endothelin-1?[J]. LifeSci,1998,62:185-193.

[5]Donckier JE.Therapeutic role of bosentan in hypertension: lesions from the model of perinephritic hypertension [J].Heart FailRev,2001,6:253-264.

[6]Pernow J,Wang QD.Endothelin in myocardial ischemia and reperfusion [J]. Cardiovasc Res,1997,33:518.

[7]Spieker LE,Mitrovic V,Noll G,et al.Acute hemody namic and neurohumoral effects ofselective ETA-receptor blockade in patients with congestive heart failure [J]. J Am Coll Cardiol,2000,35:1745-1752.

[8] Zolk O,Quatte kJ, Sitzler G,et al.Expression of endothelin-1,endothelin-converting enzyme,and endothlin receptors in chronic heart failure [J]. Circulation, 1999,99:2118-2123.

[9] Packer M,Caspi A,Charlon V,et al.Multicenter,double blind,placebo-controlled study of long-term endothelin-blockade with bosentan in chronic heart failure-results of the REACH-1trial [J]. Circulation, 1998, 98 (Suppl):S12.

[10]Torre-Amione G,Young JB,Durand JB,et al.Hemodynamic effects of tezosentan,an intravenous dual endothelin receptor antagonist,in patients with class Ⅲ to Ⅳ congestive heart failure[J].Circulation,2001,103:973-980.

[11] Wada A,Tsutamoto T,Ohnishi M,et al.Effects of a specific endothelin-converting enzyme inhibitor on cardiac,renal,and neurohumora fuctions in congestive heart failure:conparison of effects with those of endothelin-A receptor antagonism[J].Circulation,1999,99(4):570-577.

[12]CowburnPJ,Cleland JG, McArthur JD, et al. Endothelin-B receptor are functionally importantin mediating vasoconstricton in the systemic circulaton in patients with left ventricular systolic dysfunction[J].J Am CollCardiol,1999,33:932-938.

[13]林丽,袁文俊.内皮素-1与心肌电活动、心肌缺血的关系 [J].心脏杂志,2000,12(5):398-400.

备注/Memo

备注/Memo:
收稿日期：2002-1-28.
更新日期/Last Update: 2003-05-01